Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy JPMorgan Chase & Co.

Intellia Therapeutics Inc
Start price
€33.87
31.03.23 / 50%
Target price
€72.55
31.03.24
Performance (%)
-24.45%
End price
€25.59
01.04.24
Summary
This prediction ended on 01.04.24 with a price of €25.59. The prediction for Intellia Therapeutics Inc disappointed with a performance of -24.45%. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intellia Therapeutics Inc -3.048% -3.048% -39.066%
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -24.45%
Target price 72.554
Change
Ends at 31.03.24

Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at JPMorgan Chase & Co. from $82.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
31.03.23
In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) -24.45%
Target price 72.554
Change
Ends at 31.03.24

Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten

JPMorgan Chase & Co. 
0
Report Share
01.04.24

Stopped prediction by JPMorgan_Chase___Co_ for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€19.93
12.08.24
€50.28
12.08.25
-53.83%
13.08.25

JPMorgan Chase & Co. 
12.08.24 50%